Albion Financial Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$599 Hold
100
﹤0.01% 672
2025
Q4
$717 Sell
100
-40
-29% -$316 ﹤0.01% 601
2025
Q3
$1.5K Buy
140
+40
+40% +$393 ﹤0.01% 553
2025
Q2
$968 Sell
100
-3
-3% -$31 ﹤0.01% 529
2025
Q1
$1.53K Buy
103
+3
+3% +$46 ﹤0.01% 499
2024
Q4
$1.49K Hold
100
﹤0.01% 577
2024
Q3
$1.91K Hold
100
﹤0.01% 427
2024
Q2
$2.07K Hold
100
﹤0.01% 429
2024
Q1
$1.88K Hold
100
﹤0.01% 419
2023
Q4
$1.44K Hold
100
﹤0.01% 410
2023
Q3
$1.74K Hold
100
﹤0.01% 390
2023
Q2
$2.08K Sell
100
-33
-25% -$717 ﹤0.01% 383
2023
Q1
$3.13K Sell
133
-30
-18% -$806 ﹤0.01% 354
2022
Q4
$4.56K Buy
163
+30
+23% +$767 ﹤0.01% 347
2022
Q3
$3K Sell
133
-7
-5% -$211 ﹤0.01% 377
2022
Q2
$5K Hold
140
﹤0.01% 358
2022
Q1
$5K Sell
140
-7
-5% -$239 ﹤0.01% 416
2021
Q4
$4K Buy
147
+14
+11% +$456 ﹤0.01% 467
2021
Q3
$4K Hold
133
﹤0.01% 426
2021
Q2
$4K Buy
+133
New +$4.38K ﹤0.01% 423

Other funds holding OGN

Albion Financial Group's OGN Position: Q1 2026 in Review

Albion Financial Group held its Organon & Co (OGN) position steady in Q1 2026 at 100 shares worth $599. The position accounts for ﹤0.01% of the portfolio, ranked #672.

Albion Financial Group first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $5K in Q2 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Albion Financial Group held 100 shares of Organon & Co worth $599 as of Q1 2026.
  • Albion Financial Group left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of Albion Financial Group's portfolio in Q1 2026, its #672 holding.
  • Albion Financial Group first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • Albion Financial Group's Organon & Co position peaked at $5K in Q2 2022.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Albion Financial Group's 13F filing for Q1 2026, filed 27 Apr 2026.